0.00Open0.05Pre Close0 Volume728 Open Interest2.50Strike Price0.00Turnover5713.81%IV127.68%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1691Delta0.3598Gamma22.40Leverage Ratio-2.4414Theta0.0000Rho3.79Eff Leverage0.0000Vega
Cosmos Health Stock Discussion
Cosmos Health Inc., a diversified, vertically integrated global healthcare group, has made strides in expanding its contract manufacturing capabilities through its wholly-owned subsidiary, Cana Laboratories. The company recently announced a new agreement with Prov...
Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule
Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units
Cosmos Health (NASDAQ:COSM) announced that its subsidiary, Cana Laboratories, has secured additional contract manufacturing agreements with Provident Pharmaceuticals. The new orders include:
408,000 units of MIOREL for muscle spasms
222,000 units of CALCIFOLIN for nucleic acid synthesis
72,000 units...
Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market
Cosmos Health (NASDAQ:COSM) announced the successful completion of the pilot production and scale-up phases for its weight management solution, CCX0722, a biocompatible hydrogel. These milestones mark the end of the development phase, following earlier project updates such as the...
up up up to 1.60
No comment yet